Dean Karavite
University of Michigan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dean Karavite.
American Journal of Cardiology | 2001
Michael H. Kim; G. Michael Deeb; Fred Morady; David Bruckman; Lucille R Hallock; Kaye Smith; Dean Karavite; Steven F. Bolling; Francis D. Pagani; Joyce A. Wahr; Seema S. Sonnad; Paul E. Kazanjian; Charles Watts; Michael L. Williams; Kim A. Eagle
Atrial fibrillation (AF) after cardiac surgery is thought to increase length of stay (LOS). A clinical pathway focused on the management of postoperative AF, including prophylaxis with beta blockers, was implemented to assess the effect of AF on LOS after cardiac surgery. Data were obtained on consecutive cardiac surgery patients in preoperative normal sinus rhythm, no prior history of AF, and no chronic antiarrhythmic therapy from January to May 1995 (control) and November 1996 to June 1997 (pathway). Statistical analysis was performed to assess the effect of postoperative AF on the LOS, clinical outcomes, and cost after cardiac surgery. Despite the clinical pathway, the LOS (7 days for both periods; p = 0.12) and incidence of AF (28.9% vs 28.4%; p = 0.92) remained unchanged. Unadjusted direct costs were 15% higher in the pathway period (p <0.001). Increased rates of beta-blocker therapy had a marginal effect on the incidence of postoperative AF, except in the group who only underwent primary coronary artery bypass graft surgery (31.2% vs 25.3%; p = 0.31). Multivariate analysis revealed that AF contributed only 1 to 1.5 days to the LOS. Thus, this investigation represents the most recent analysis of the effects of postoperative AF on LOS, clinical outcomes, and cost after cardiac surgery. Unlike prior studies, the impact of postoperative AF is less prominent in the current era of cardiac surgical care regardless of the presence of a clinical pathway addressing AF.
Journal of the American College of Cardiology | 1999
Mauro Moscucci; Gerald T. O'Connor; Stephen G. Ellis; David J. Malenka; Jennifer Sievers; Eric R. Bates; David W.M. Muller; Steven W. Werns; Eva Kline Rogers; Dean Karavite; Kim A. Eagle
OBJECTIVES We sought to validate recently proposed risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty (PTCA) mortality on an independent data set of high risk patients undergoing PTCA. BACKGROUND Risk adjustment models for PTCA mortality have recently been reported, but external validation on independent data sets and on high risk patient groups is lacking. METHODS Between July 1, 1994 and June 1, 1996, 1,476 consecutive procedures were performed on a high risk patient group characterized by a high incidence of cardiogenic shock (3.3%) and acute myocardial infarction (14.3%). Predictors of in-hospital mortality were identified using multivariate logistic regression analysis. Two external models of in-hospital mortality, one developed by the Northern New England Cardiovascular Disease Study Group (model NNE) and the other by the Cleveland Clinic (model CC), were compared using receiver operating characteristic (ROC) curve analysis. RESULTS In this patient group, an overall in-hospital mortality rate of 3.4% was observed. Multivariate regression analysis identified risk factors for death in the hospital that were similar to the risk factors identified by the two external models. When fitted to the data set, both external models had an area under the ROC curve >0.85, indicating overall excellent model discrimination, and both models were accurate in predicting mortality in different patient subgroups. There was a trend toward a greater ability to predict mortality for model NNE as compared with model CC, but the difference was not significant. CONCLUSIONS Predictive models for PTCA mortality yield comparable results when applied to patient groups other than the one on which the original model was developed. The accuracy of the two models tested in adjusting for the relatively high mortality rate observed in this patient group supports their application in quality assessment or quality improvement efforts.
American Journal of Cardiology | 1998
Mauro Moscucci; Mark J. Ricciardi; Kim A. Eagle; Eva M. Kline; Eric R. Bates; Steven W. Werns; Dean Karavite; David W.M. Muller
Increased awareness of the risks of blood-borne infections has recently led to profound changes in the practice of transfusion medicine. These changes include, among others, the development of guidelines by the American College of Physicians (ACP) for transfusion. Although the incidence and predictors of vascular complications of percutaneous interventions have been well defined, there are currently no data on frequency, risk factors, and appropriateness of blood transfusions. We performed a retrospective analysis of 628 consecutive percutaneous coronary revascularization procedures. Predictors of blood transfusion were identified using multivariate logistic regression analysis. Appropriateness of transfusions was determined using modified ACP guidelines. Transfusions were administered after 8.9% of interventions (56 of 628). Multivariate analysis identified age >70 years, female gender, procedure duration, coronary stenting, acute myocardial infarction, postprocedural use of heparin and intra-aortic balloon pump placement as independent predictors of blood transfusions (all p <0.05). According to the ACP guidelines, 36 of 56 patients (64%) received transfusions inappropriately. Transfusion reactions (fever) occurred in 10% of patients who received tranfusions appropriately and in 5% of patients who received tranfusions inappropriately. The estimated additional costs per procedure related to transfusions were
American Journal of Cardiology | 2000
Sharlene M. Day; John G. Younger; Dean Karavite; David S. Bach; William F. Armstrong; Kim A. Eagle
551 and
The American Journal of Medicine | 2002
James P. Smith; Rajendra H. Mehta; Sugata Das; Thomas C. Tsai; Dean Karavite; Pamela L. Russman; David Bruckman; Kim A. Eagle
419, respectively. In conclusion, unnecessary transfusions were performed frequently after percutaneous coronary interventions. Application of available guidelines could reduce the number of unnecessary transfusions, thus avoiding exposure of patients to additional risks and reducing procedural costs.
JAMA | 2000
Peter G. Hagan; Christoph Nienaber; Eric M. Isselbacher; David Bruckman; Dean Karavite; Pamela L. Russman; Rossella Fattori; Toru Suzuki; Jae K. Oh; Andrew G. Moore; Joseph F. Malouf; Linda A. Pape; Charlene Gaca; Udo Sechtem; Suzanne Lenferink; Hans Josef; Holger Diedrichs; Jose Marcos; Alfredo Llovet; Dan Gilon; Sugata Das; William F. Armstrong; G. Michael Deeb; Kim A. Eagle
This study was undertaken to determine the prognostic significance of hypotension induced during preoperative dobutamine stress echocardiography (DSE) before vascular and noncardiac thoracic surgery. Wall motion abnormality during DSE predicts perioperative risk. Although hypotension during DSE has not been shown to correlate with the presence or severity of coronary artery disease, its significance in perioperative risk assessment is unknown. We retrospectively studied 300 patients who had DSE within 6 months of noncardiac surgery. Perioperative events including death, myocardial infarction, ischemia, and arrhythmias were recorded. Odds ratios with 95% confidence intervals were used to examine the association between clinical and echocardiographic variables and perioperative events. A hypotensive response during DSE was seen in 85 patients (28%). Forty-eight patients (16%) had 54 perioperative complications including 4 cardiac-related deaths, 10 myocardial infarctions, 12 myocardial ischemic events, and 28 arrhythmias. Hypotension during DSE was predictive of the combined end point of perioperative cardiac mortality, myocardial infarction, and ischemia (odds ratio 4.04, 95% confidence interval 1.72 to 9.51). In a multivariate logistic regression model, hypotension during DSE remained a significant predictor (odds ratio 4.10, p<0.01). DSE-related hypotension was predictive of perioperative cardiac events and therefore may have a role in risk stratification before vascular or noncardiac thoracic surgery.
American Heart Journal | 2002
Michele Doughty; Raj Mehta; David Bruckman; Sugata Das; Dean Karavite; Thomas C. Tsai; Kim A. Eagle
PURPOSE We studied whether transfer of care when house staff and faculty switch services affects length of stay or quality of care among hospitalized patients. SUBJECTS AND METHODS We performed a retrospective analysis in 976 consecutive patients admitted with myocardial infarction from 1995 to 1998. Patients who were admitted within 3 days of change in staff were denoted end-of-month patients. RESULTS Of 782 eligible patients, 690 (88%) were admitted midmonth and 92 (12%) at the end of the month. The median length of stay was 7 days for midmonth and 8 days for end-of-month patients (P = 0.06). End-of-month admission was an independent predictor of length of stay in multivariate models. In addition, a significant difference in length of stay was noted between patients admitted at the beginning and end of the academic year. There were no statistically significant differences in the use of aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, or lipid-lowering agents at discharge between midmonth and end-of-month patients. Mortality and in-hospital adverse events did not differ between the two groups, with the possible exception of a greater incidence of acute renal failure in the end-of-month patients. CONCLUSIONS Although admission during the last 3 days of the month is an independent predictor of length of stay, it does not have a large effect on quality of care among patients with myocardial infarction.
The Annals of Thoracic Surgery | 1997
G. Michael Deeb; David M. Williams; Steven F. Bolling; Leslie E. Quint; Hilary Monaghan; Jennifer Sievers; Dean Karavite; Michael J. Shea
The Journal of Thoracic and Cardiovascular Surgery | 2001
Rajendra H. Mehta; David Bruckman; Sugata Das; Thomas C. Tsai; Pamela L. Russman; Dean Karavite; Hillary Monaghan; Seema S. Sonnad; Michael J. Shea; Kim A. Eagle; G. Michael Deeb
American Heart Journal | 2000
Rosario V. Freeman; Kim A. Eagle; Eric R. Bates; Steven W. Werns; Eva Kline-Rogers; Dean Karavite; Mauro Moscucci